The Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Clinical trial NCT01901341 · TERMINATED
Trial details
- NCT number
- NCT01901341
- Sponsor
- Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-02
- Primary completion
- 2014-02-13
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.